In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on TransMedics Group (TMDX – Research Report), with a price ...

Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

In recent trading, TransMedics Group Inc (TMDX) stock price has shown some volatility, fluctuating 10.37% over the last five trades and -3.29% over the past 30 trades. This represents a notable shift ...